Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1980 3
1986 1
1989 2
1990 1
1993 1
1994 1
1996 1
1997 3
1998 1
1999 1
2000 3
2001 1
2002 3
2003 1
2004 1
2006 2
2007 1
2008 3
2009 3
2010 3
2011 4
2013 2
2014 2
2015 5
2016 8
2017 10
2018 12
2019 12
2020 7
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32205320

90 results
Results by year
Filters applied: . Clear all
Page 1
Use of Checkpoint Inhibitors in a Kidney Transplant Recipient with Metastatic Cancer.
Ong SC, Mannon RB. Ong SC, et al. Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1190-1192. doi: 10.2215/CJN.15941219. Epub 2020 Mar 23. Clin J Am Soc Nephrol. 2020. PMID: 32205320 No abstract available.
Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient.
Herz S, Höfer T, Papapanagiotou M, Leyh JC, Meyenburg S, Schadendorf D, Ugurel S, Roesch A, Livingstone E, Schilling B, Franklin C. Herz S, et al. Eur J Cancer. 2016 Nov;67:66-72. doi: 10.1016/j.ejca.2016.07.026. Epub 2016 Sep 8. Eur J Cancer. 2016. PMID: 27614165
Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report.
Kwatra V, Karanth NV, Priyadarshana K, Charakidis M. Kwatra V, et al. J Med Case Rep. 2017 Mar 19;11(1):73. doi: 10.1186/s13256-017-1229-z. J Med Case Rep. 2017. PMID: 28315636 Free PMC article.
The transmission of donor-derived malignant melanoma to a renal allograft recipient.
Milton CA, Barbara J, Cooper J, Rao M, Russell C, Russ G. Milton CA, et al. Clin Transplant. 2006 Sep-Oct;20(5):547-50. doi: 10.1111/j.1399-0012.2006.00514.x. Clin Transplant. 2006. PMID: 16968479
Use of Ipilimumab and Pembrolizumab in Metastatic Melanoma in a Combined Heart and Kidney Transplant Recipient: A Case Report.
Soellradl I, Kehrer H, Cejka D. Soellradl I, et al. Transplant Proc. 2020 Mar;52(2):657-659. doi: 10.1016/j.transproceed.2019.09.014. Epub 2020 Feb 8. Transplant Proc. 2020. PMID: 32044081
Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single-center analysis.
Owoyemi I, Vaughan LE, Costello CM, Thongprayoon C, Markovic SN, Herrmann J, Otley CC, Taner T, Mangold AR, Leung N, Herrmann SM, Kukla A. Owoyemi I, et al. Cancer. 2020 Aug 12. doi: 10.1002/cncr.33134. Online ahead of print. Cancer. 2020. PMID: 32786022
Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment.
Hurkmans DP, Verhoeven JGHP, de Leur K, Boer K, Joosse A, Baan CC, von der Thüsen JH, van Schaik RHN, Mathijssen RHJ, van der Veldt AAM, Hesselink DA. Hurkmans DP, et al. J Immunother Cancer. 2019 Jul 12;7(1):182. doi: 10.1186/s40425-019-0653-6. J Immunother Cancer. 2019. PMID: 31300068 Free PMC article.
Immune Checkpoint Inhibitors in Organ Transplant Patients.
Kittai AS, Oldham H, Cetnar J, Taylor M. Kittai AS, et al. J Immunother. 2017 Sep;40(7):277-281. doi: 10.1097/CJI.0000000000000180. J Immunother. 2017. PMID: 28719552 Review.
Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword?
Lai HC, Lin JF, Hwang TIS, Liu YF, Yang AH, Wu CK. Lai HC, et al. Int J Mol Sci. 2019 May 3;20(9):2194. doi: 10.3390/ijms20092194. Int J Mol Sci. 2019. PMID: 31058839 Free PMC article. Review.
Transplant surgery injury recruits recipient MHC class II-positive leukocytes into the kidney.
Penfield JG, Wang Y, Li S, Kielar MA, Sicher SC, Jeyarajah DR, Lu CY. Penfield JG, et al. Kidney Int. 1999 Nov;56(5):1759-69. doi: 10.1046/j.1523-1755.1999.00741.x. Kidney Int. 1999. PMID: 10571784 Free article.
90 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback